These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Osorio RS; Ayappa I; Mantua J; Gumb T; Varga A; Mooney AM; Burschtin OE; Taxin Z; During E; Spector N; Biagioni M; Pirraglia E; Lau H; Zetterberg H; Blennow K; Lu SE; Mosconi L; Glodzik L; Rapoport DM; de Leon MJ Neurobiol Aging; 2014 Jun; 35(6):1318-24. PubMed ID: 24439479 [TBL] [Abstract][Full Text] [Related]
11. Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Fagan AM; Shaw LM; Xiong C; Vanderstichele H; Mintun MA; Trojanowski JQ; Coart E; Morris JC; Holtzman DM Arch Neurol; 2011 Sep; 68(9):1137-44. PubMed ID: 21555603 [TBL] [Abstract][Full Text] [Related]
12. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756 [TBL] [Abstract][Full Text] [Related]
14. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR; Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342 [TBL] [Abstract][Full Text] [Related]
15. The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease. Glodzik-Sobanska L; Pirraglia E; Brys M; de Santi S; Mosconi L; Rich KE; Switalski R; Saint Louis L; Sadowski MJ; Martiniuk F; Mehta P; Pratico D; Zinkowski RP; Blennow K; de Leon MJ Neurobiol Aging; 2009 May; 30(5):672-81. PubMed ID: 17920160 [TBL] [Abstract][Full Text] [Related]
16. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Luo J; Agboola F; Grant E; Masters CL; Albert MS; Johnson SC; McDade EM; Vöglein J; Fagan AM; Benzinger T; Massoumzadeh P; Hassenstab J; Bateman RJ; Morris JC; Perrin RJ; Chhatwal J; Jucker M; Ghetti B; Cruchaga C; Graff-Radford NR; Schofield PR; Mori H; Xiong C Neurology; 2020 Dec; 95(23):e3104-e3116. PubMed ID: 32873693 [TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Fagan AM; Head D; Shah AR; Marcus D; Mintun M; Morris JC; Holtzman DM Ann Neurol; 2009 Feb; 65(2):176-83. PubMed ID: 19260027 [TBL] [Abstract][Full Text] [Related]